BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 15734726)

  • 1. Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments.
    Kreek MJ; Bart G; Lilly C; LaForge KS; Nielsen DA
    Pharmacol Rev; 2005 Mar; 57(1):1-26. PubMed ID: 15734726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurobiology of addictive behaviors and its relationship to methadone maintenance.
    Stimmel B; Kreek MJ
    Mt Sinai J Med; 2000; 67(5-6):375-80. PubMed ID: 11064487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale for maintenance pharmacotherapy of opiate dependence.
    Kreek MJ
    Res Publ Assoc Res Nerv Ment Dis; 1992; 70():205-30. PubMed ID: 1346939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic determinants of addiction to opioids and cocaine.
    Saxon AJ; Oreskovich MR; Brkanac Z
    Harv Rev Psychiatry; 2005; 13(4):218-32. PubMed ID: 16126608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment.
    Yuferov V; Levran O; Proudnikov D; Nielsen DA; Kreek MJ
    Ann N Y Acad Sci; 2010 Feb; 1187():184-207. PubMed ID: 20201854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics of dopamine and its contribution to cocaine addiction.
    Haile CN; Kosten TR; Kosten TA
    Behav Genet; 2007 Jan; 37(1):119-45. PubMed ID: 17063402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment.
    Crettol S; Besson J; Croquette-Krokar M; Hämmig R; Gothuey I; Monnat M; Déglon JJ; Preisig M; Eap CB
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1722-7. PubMed ID: 18687376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opiate and cocaine addiction: from bench to clinic and back to the bench.
    Kreek MJ; Zhou Y; Butelman ER; Levran O
    Curr Opin Pharmacol; 2009 Feb; 9(1):74-80. PubMed ID: 19155191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical evidence of new opioid modulators for the treatment of addiction.
    Rodríguez-Arias M; Aguilar MA; Manzanedo C; Miñarro J
    Expert Opin Investig Drugs; 2010 Aug; 19(8):977-94. PubMed ID: 20629615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics.
    Kreek MJ; Levran O; Reed B; Schlussman SD; Zhou Y; Butelman ER
    J Clin Invest; 2012 Oct; 122(10):3387-93. PubMed ID: 23023708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics of opiates in clinical practice: the visible tip of the iceberg.
    Hajj A; Khabbaz L; Laplanche JL; Peoc'h K
    Pharmacogenomics; 2013 Apr; 14(5):575-85. PubMed ID: 23556453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opiate addiction in China: current situation and treatments.
    Tang YL; Zhao D; Zhao C; Cubells JF
    Addiction; 2006 May; 101(5):657-65. PubMed ID: 16669899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid abuse and brain gene expression.
    Przewlocki R
    Eur J Pharmacol; 2004 Oct; 500(1-3):331-49. PubMed ID: 15464044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological treatment of substance dependence from a neuroscientific perspective (I): opiates and cocaine].
    Haro G; Cervera G; Martínez-Raga J; Pérez-Gálvez B; Fernández-Garcés M; Sanjuan J
    Actas Esp Psiquiatr; 2003; 31(4):205-19. PubMed ID: 12838444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving perspectives on neurobiological research on the addictions: celebration of the 30th anniversary of NIDA.
    Kreek MJ; Schlussman SD; Bart G; Laforge KS; Butelman ER
    Neuropharmacology; 2004; 47 Suppl 1():324-44. PubMed ID: 15464148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug addictions. Molecular and cellular endpoints.
    Kreek MJ
    Ann N Y Acad Sci; 2001 Jun; 937():27-49. PubMed ID: 11458539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cocaine, dopamine and the endogenous opioid system.
    Kreek MJ
    J Addict Dis; 1996; 15(4):73-96. PubMed ID: 8943583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of lymphocyte opioid receptors in methadone maintenance subjects.
    Toskulkao T; Pornchai R; Akkarapatumwong V; Vatanatunyakum S; Govitrapong P
    Neurochem Int; 2010 Jan; 56(2):285-90. PubMed ID: 19913582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variants of opioid system genes are associated with non-dependent opioid use and heroin dependence.
    Randesi M; van den Brink W; Levran O; Blanken P; Butelman ER; Yuferov V; da Rosa JC; Ott J; van Ree JM; Kreek MJ
    Drug Alcohol Depend; 2016 Nov; 168():164-169. PubMed ID: 27664554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.